Severe cold hemagglutinin disease (CHD) successfully treated with rituximab
Open Access
- 1 September 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (5) , 1922-1923
- https://doi.org/10.1182/blood-2002-04-1213
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemiaBlood, 2002
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Treatment of childhood autoimmune haemolytic anaemia with rituximabThe Lancet, 2001
- Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpuraBlood, 2001
- Remission of severe cold agglutinin disease Rituximab therapyLeukemia, 2001
- Rituxan in the Treatment of Cold Agglutinin DiseaseBlood, 1998
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998
- Mycophenolate mofetil for severe autoimmune haemolytic anemiaThe Lancet, 1997
- Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20Blood, 1994